Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 226 | resTORbio | Post Ipo Equity | $50.0M | Boston, United States |
| 227 | Peloton Therapeutics | Series E | $150.0M | Dallas, United States |
| 228 | Modis Therapeutics | Series A | $30.0M | Oakland, United States |
| 229 | Bsense Bio Therapeutics | Seed | $405K | Ness Ziona, Israel |
| 230 | KaNDy Therapeutics | Series C | $32.6M | Stevenage, United Kingdom |
| 231 | Therachon | Series B | $60.0M | Basel, Switzerland |
| 232 | ARMO BioSciences | Series Unknown | Undisclosed | Redwood City, United States |
| 233 | True North Therapeutics | Series Unknown | Undisclosed | South San Francisco, United States |
| 234 | Tisbury Pharmaceuticals | Series A | $32.0M | Beverly, United States |
| 235 | Rhythm Metabolic | Series A | $40.0M | Boston, United States |
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders.
KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.
Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company.
Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.
Seragon Pharmaceuticals is a research-based company dedicated to improving human and animal health through innovative science.
Angelalign is a global service provider of invisible orthodontic technology and invisible orthodontics production and sales.
Arteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine.
Kalidex Pharmaceuticals develops quinolones to fight infections caused by multi-drug resistant organisms.
OrbiMed has invested in 239 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Clinical Trials. The firm invests across 14 different industry categories.
Among tracked funding rounds, Peloton Therapeutics received $150.0M in a Series E round. OrbiMed's total known invested capital is $12.2B.
OrbiMed's average investment size is $87.5M across its portfolio of 239 companies.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors